{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:48:55Z","timestamp":1781945335141,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["2006AA02A305"],"award-info":[{"award-number":["2006AA02A305"]}]},{"name":"the National Key New Drug Creation Program of China","award":["2009ZX09503-004"],"award-info":[{"award-number":["2009ZX09503-004"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30872292"],"award-info":[{"award-number":["30872292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["90813025"],"award-info":[{"award-number":["90813025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special fund for promotion of education P.R.C.","award":["985-2-032-24"],"award-info":[{"award-number":["985-2-032-24"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.bbrc.2010.04.068","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T09:02:05Z","timestamp":1271322125000},"page":"224-230","source":"Crossref","is-referenced-by-count":27,"title":["Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells"],"prefix":"10.1016","volume":"396","author":[{"given":"Lin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quansheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2010.04.068_bib1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia \u2013 advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2010.04.068_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2010.04.068_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/14656566.4.6.963","article-title":"Imatinib mesylate in the treatment of chronic myeloid leukaemia","volume":"4","author":"Druker","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bbrc.2010.04.068_bib4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2010.04.068_bib5","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","article-title":"Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study","volume":"99","author":"Talpaz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2010.04.068_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/bbrc.1998.9893","article-title":"TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal","volume":"254","author":"Liu","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.04.068_bib7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1242\/jcs.00994","article-title":"An alternative form of paraptosis-like cell death, triggered by TAJ\/TROY and enhanced by PDCD5 overexpression","volume":"117","author":"Wang","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2010.04.068_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200102223440801","article-title":"Gene-expression profiles in hereditary breast cancer","volume":"344","author":"Hedenfalk","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2010.04.068_bib9","first-page":"573","article-title":"Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas","volume":"20","author":"Li","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2010.04.068_bib10","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1158\/1078-0432.CCR-05-0039","article-title":"Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5\u2032 regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population","volume":"11","author":"Ma","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2010.04.068_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.leukres.2005.12.028","article-title":"Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia","volume":"30","author":"Ruan","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2010.04.068_bib12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.2005.04.4339","article-title":"Association of the PDCD5 locus with lung cancer risk and prognosis in smokers","volume":"24","author":"Spinola","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2010.04.068_bib13","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.241522398","article-title":"Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver","volume":"98","author":"Xu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2010.04.068_bib14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10495-006-6714-6","article-title":"Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells","volume":"11","author":"Yang","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2010.04.068_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10495-005-3134-y","article-title":"Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression","volume":"11","author":"Chen","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2010.04.068_bib16","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0024-3205(02)01943-4","article-title":"Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis","volume":"71","author":"Rui","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2010.04.068_bib17","doi-asserted-by":"crossref","first-page":"24803","DOI":"10.1074\/jbc.M600183200","article-title":"Cellular uptake of exogenous human PDCD5 protein","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.04.068_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10495-008-0206-9","article-title":"Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo","volume":"13","author":"Ruan","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2010.04.068_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2010.04.068_bib20","first-page":"4619","article-title":"Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model","volume":"9","author":"Plum","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2010.04.068_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm735","article-title":"Smac agonists sensitize for Apo2L\/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo","volume":"8","author":"Fulda","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.04.068_bib22","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2007-12-130211","article-title":"TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice","volume":"112","author":"Zhou","year":"2008","journal-title":"Blood"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10007370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10007370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:25:19Z","timestamp":1559042719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X10007370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0006291X10007370"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.04.068","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}